Lupin has informed that it enclosed a Press Release regarding receipt of Establishment Inspection Report from US FDA for the Company’s manufacturing facility in Somerset, New Jersey, for the inspection conducted from January 27 to January 31, 2025.
The above information is a part of company’s filings submitted to BSE.